NCT05014763

Brief Summary

This study will compare peri implant tissue stability following connective tissue graft harvested fromLateral Palate or the Tuberosity Area. As far as we know, it remains controversial whether peri-implant soft tissue stability could be achieved after soft tissue augmentation with the connective tissue graft from the tuberosity or the lateral palate. Soft tissue stability evaluated by intra oral scanner will be described as primary outcome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2021

Completed
25 days until next milestone

First Posted

Study publicly available on registry

August 20, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

September 20, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2022

Completed
Last Updated

August 20, 2021

Status Verified

July 1, 2021

Enrollment Period

1 year

First QC Date

July 26, 2021

Last Update Submit

August 19, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • soft tissue volume change 0-3

    changes of soft tissue volume from baseline (immediately before surgery) to 3 months by intra oral scanner

    from baseline (immediately before surgery) to 3 months

  • soft tissue volume change 0-6

    changes of soft tissue volume from baseline (immediately before surgery) to 6 months by intra oral scanner

    from baseline (immediately before surgery) to 6 months

  • soft tissue volume change 3-6

    changes of soft tissue volume from 3 months to 6 months by intra oral scanner

    from 3 months to 6 months

Secondary Outcomes (11)

  • The level of the pain by questionnaire through visual analogue scale

    immediately after surgery

  • The level of the pain by questionnaire through visual analogue scale

    day 1

  • The level of the pain by questionnaire through visual analogue scale

    day 2

  • The level of the pain by questionnaire through visual analogue scale

    day 3

  • The level of the pain by questionnaire through visual analogue scale

    day 4

  • +6 more secondary outcomes

Study Arms (2)

CTG from deep palate

ACTIVE COMPARATOR

The connective tissue graft harvested from the deep palate during flap elevation for implant placement

Procedure: connective tissue graft

CTG from tuberosity

EXPERIMENTAL

The connective tissue graft harvested from the tuberosity

Procedure: connective tissue graft

Interventions

Connective tissue graft surgery will be done for increasing soft tissue volume. In this methods connective tissue will be harvested from lateral palate or tuberosity area.

CTG from deep palateCTG from tuberosity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • more than 18 years old.
  • systemically and periodontally healthy patients.
  • need of single implant placement between two maxillary teeth.
  • need of tissue augmentation due to concavity or soft tissue thickness less than 2 millimetres .
  • more than 3 month after extraction.
  • full mouth plaque index lesser than 20%.
  • sufficient mesiodistal and buccolingual space.
  • At least 10 millimetres mesiodistal dimension in tuberosity.
  • sufficient implant primary stability.
  • at least 6 mm crestal ridge width.

You may not qualify if:

  • History of periodontitis and radiotherapy.
  • Need of horizontal ridge augmentation.
  • Previous soft tissue augmentation.
  • Heavy smoker( more than 10 cigarette per day)
  • Local or systemic conditions that would interfere with routine periodontal therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tehran University of Medical Sciences

Tehran, Iran

Location

Study Officials

  • Neda Moslemi, Periodontist

    Tehran University of Medical Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Neda Moslemi, Periodontist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2021

First Posted

August 20, 2021

Study Start

September 20, 2021

Primary Completion

September 20, 2022

Study Completion

December 20, 2022

Last Updated

August 20, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations